Xenotransplantation

Xenotransplantation is the transfer of living cells, tissues or organs between different species, e.g. from pigs to humans.

This method is seen as a potential solution to the shortage of human donor organs.

A key problem is the rejection reaction, which is more severe than in transplants between humans. To circumvent this, genetically modified animals are used whose organs are better tolerated.

In Europe, clinical studies on xenotransplantation are monitored by a combination of national and European regulations. The European Medicines Agency (EMA) plays a key role in assessing the safety and effectiveness of such procedures. National health authorities, such as the Paul Ehrlich Institute in Germany, are also involved, particularly in the authorisation and monitoring of studies.

Can we support you too? You are welcome to arrange a first non-binding appointment here.